Ken Alltucker
Ken Alltucker follows the money through the health care system, showing how insurance rules, drug prices and federal programs determine what care people receive and how much they pay. He is a consumer health reporter at USA TODAY, covering national health care with an emphasis on medical advances, insurance boondoggles, surprise medical bills and regulatory hurdles. His work sits inside USA TODAY’s Lifestyle & Financial Wellness group and often anchors the Daily Money newsletter, tying health coverage directly to personal finance and household budgets.
Health insurance costs and coverage gaps
Alltucker’s core focus is the cost and structure of health insurance and what that means for people trying to get care. He explains looming premium changes for Affordable Care Act marketplace plans, detailing why individuals who buy coverage on the exchanges face double-digit rate increases in the coming year. His reporting breaks down the forces driving health insurance prices higher, translating policy and market shifts into clear expectations for consumers.
He pays close attention to how insurance fails even when people have coverage.
In one Daily Money piece, he highlights survey findings that one in three working-age adults with private health insurance owe money to a hospital, doctor or other provider, underscoring how medical bills push insured patients into debt. He also reports on anti-fraud crackdowns that will remove about 760,000 enrollees from Affordable Care Act exchanges, showing how enforcement actions can abruptly strip people of coverage.
Beyond broad trends, he looks at the mechanics of denial and restriction. His work on private Medicare plans includes reporting on plans that deny specialized care at high rates, connecting utilization review and narrow benefit rules with real limits on access for older patients.
He uses these stories to show how coverage decisions at the plan level translate into delayed or foregone care, even when people believe they are fully insured.
Medicare, Medicaid and federal health programs
Medicare and Medicaid are a recurring thread in Alltucker’s coverage, and he treats them as financial systems as much as health programs.
He breaks down upcoming rate changes for private Medicare and stand-alone prescription drug plans, reporting that millions of older Americans could see lower monthly prices for their Medicare Advantage coverage while average Part D premiums are projected to rise by less than $1. He notes that drug lists and provider networks can still shift before enrollment, alerting readers that headline premium figures do not capture every change.
His reporting extends to policy decisions that shape what these programs will cover. He follows Medicare’s handling of GLP‑1 weight-loss drugs, documenting the postponement of a program that would have required participating insurers to cover certain medications and raising questions about future access for beneficiaries.
He has also covered national Medicaid drug-pricing agreements across all 50 states, treating those deals as part of a broader effort to manage the cost of care in public insurance.
Alltucker contributes to coverage of high-profile political maneuvers tied to federal health programs.
He has reported on plans to send $500 Affordable Care Act refund checks to roughly 1 million Americans, situating that move within ongoing battles over the law and its financing. These pieces show him following how political decisions play out in cash terms for consumers, not just in partisan headlines.
Prescription drugs and weight-loss treatments
Prescription drug pricing and access are another pillar of Alltucker’s beat. He has examined blockbuster cancer therapies such as Keytruda, reporting that its treatment regimen can cost more than $150,000 and exploring why prices vary so widely.
He brings that work into audio formats as well, joining a podcast to discuss an investigation into what Americans pay for such drugs and what that means for patients who need them.
He devotes sustained attention to GLP‑1 weight-loss medications and their rapid spread.
His coverage of injectable drugs like Wegovy and Zepbound explores how they are changing the way Americans receive obesity care and the new demands they place on insurers and health systems. In a personal finance–focused health care story, he looks at “microdosing” GLP‑1s, explaining how people use smaller doses to shed pounds and laying out the medical dangers and side effects that can come with these regimens.
These stories sit at the intersection of lifestyle, clinical evidence and financial risk, showing how new treatments move from headlines into everyday budgets.
Regulation, fraud and the business of care
Regulation, enforcement and the business side of health care run through Alltucker’s work.
His author bio notes that his coverage ranges from insurance boondoggles and surprise medical bills to regulatory hurdles, and he regularly shows how rules and loopholes affect the bills people receive and the care they can access. The Daily Money newsletter uses his reporting to illustrate the consumer impact of government reviews, task forces and rule changes, reinforcing his role as a bridge between policy detail and financial consequences.
Before joining USA TODAY, Alltucker reported on health and business issues at The Arizona Republic, experience that informs his ability to treat hospitals, insurers and pharmaceutical companies as businesses with incentives rather than abstract institutions. Across his current work, he uses that lens to show how corporate and government decisions ripple through insurance markets, benefit designs and out-of-pocket costs, distinguishing his coverage from general finance reporting that treats health care as a minor line item rather than a central household expense.
4 more finance journalists.
Abigail Summerville
Abigail Summerville brings a leveraged finance background to her work covering consumer and retail mergers and acquisitions for Reuters. She reports on deal-making and capital markets across food, beverages, spirits, personal care, skincare, bath products and pet food. Her stories focus on transaction terms, ownership stakes, valuation, debt structures and funding sources. She often breaks news on potential sales and strategic reviews before formal announcements. Notable coverage includes Sazerac’s acquisition of Au Vodka, Blackstone’s exploration of a ZO Skin Health sale, CVC’s efforts to sell the parent of Dr Teal’s, and Colgate-Palmolive’s planned divestitures. She also covers consumer IPOs, including Jersey Mike’s and Black Rock Coffee, and co-writes Wall Street market reports. She joined Reuters in 2022 after three years covering leveraged finance and primary debt markets.
Adekunle Agbetiloye
Adekunle Agbetiloye is a senior reporter who connects capital flows, hard numbers and energy transition to the wider African economy. He works at Business Insider Africa, covering how money, technology and energy reshape economic growth, jobs and living conditions. His beat spans the African economy, technology, energy transition, climate change, startups and critical minerals, with a focus on concrete deals and data-led stories. He reports on African startup funding cycles, sovereign wealth funds, billionaire investors, multilateral and private investment programs, energy and power markets, Bitcoin mining, and economic policy choices. His work follows how governments finance spending, manage debt and respond to social pressure, and how sector snapshots and health and development metrics reveal links between macro indicators, corporate strategy and everyday costs.
Aimee Picchi
Aimee Picchi connects Social Security, retirement programs and economic policy directly to the financial security of ordinary Americans, showing how macro decisions hit household budgets. She is associate managing editor for CBS MoneyWatch at CBS News, covering business and personal finance with clear, accessible explanations of complex money issues. Her core beat is Social Security and retirement, interest rates and inflation, and how policy, markets and company strategies affect workers, retirees, savers and investors. She reports on benefit adequacy, looming Social Security cuts, COLA changes, Federal Reserve rate decisions, fuel costs, trade tensions and labor’s share of income, always framing coverage around pocketbook impacts. Her background includes retirement reporting fellowships, prior staff reporting on technology, media and business, an Institutional Investor book on affluent investors, and freelance work for national outlets. She also writes science fiction and fantasy and is a Nebula Award finalist.
Alex Harring
Alex Harring turns fast-moving market, economic and corporate developments into clear pre-market briefings that show what will matter when U.S. trading opens. He is a markets and economics reporter for CNBC’s digital platforms and writes Morning Squawk, a flagship daily newsletter that gives readers five key things to know before the stock market opens. His beat spans financial markets, investing, consumer trends and the U.S. economy, with coverage of central bank decisions, inflation, corporate strategy, sector moves and geopolitical shocks. He focuses on how policy, data and earnings shape equities, interest rates, currencies and investor positioning, linking price action with underlying drivers in real time and in reported features. Harring’s background reporting on corporate news, business and the economy across print, digital, broadcast and streaming informs his habit of connecting markets, companies and geopolitics in one frame.